| 1 | exp Prostatic Neoplasms/ (290920) |
| 2 | Prostate/ (74575) |
| 3 | exp Neoplasms/ (6500732) |
| 4 | 2 and 3 (38049) |
| 5 | (prostat* adj3 (cancer* or carcinoma* or neoplas* or tumo?r* or adenoma* or adenocarcinoma* or malignan* or metasta*)).tw. (277087) |
| 6 | Prostatectomy/ (69779) |
| 7 | prostatectom*.tw. (63158) |
| 8 | or/1,4–7 (373736) |
| 9 | Genetic Testing/ (60447) |
| 10 | ((genetic* or gene or genes or genome or genomes or genomic* or 17-gene) adj2 (test or tests or testing or panel* or assess* or screen* or profil* or algorithm* or combinatorial or prognosis or prognostic*)).tw. (235791) |
| 11 | exp Gene Expression Profiling/ (171739) |
| 12 | ((gene expression adj (profiling* or monitoring* or analys?s or test or tests or testing)) or transcript expression analys?s or (transcriptome adj (analys?s or profiling*)) or (mrna adj differential display*)).tw. (69757) |
| 13 | ((cell cycle progression adj (score or scores or test or tests or testing or assay* or signature* or instrument*)) or (CCP adj (score or scores or test or tests or testing)) or cell cycle gene expression assay* or cell cycle proliferation gene* or RNA profiling test* or molecular assay* or prostate cancer assay* or genomic prostate score* or molecular diagnostic assay* or multigene expression assay*).tw. (5822) |
| 14 | or/9–13 (429710) |
| 15 | 8 and 14 (6949) |
| 16 | prolaris*.tw. (31) |
| 17 | or/15–16 (6958) |
| 18 | economics/ (251267) |
| 19 | economics, medical/ or economics, pharmaceutical/ or exp economics, hospital/ or economics, nursing/ or economics, dental/ (735077) |
| 20 | economics.fs. (381957) |
| 21 | (econom* or price or prices or pricing or priced or discount* or expenditure* or budget* or pharmacoeconomic* or pharmaco-economic*).tw. (686871) |
| 22 | exp “costs and cost analysis”/ (510897) |
| 23 | cost*.ti. (234727) |
| 24 | cost effective*.tw. (250095) |
| 25 | (cost* adj2 (util* or efficacy* or benefit* or minimi* or analy* or saving* or estimate* or allocation or control or sharing or instrument* or technolog*)).ab. (156523) |
| 26 | models, economic/ (134522) |
| 27 | markov chains/ or monte carlo method/ (119887) |
| 28 | (decision adj1 (tree* or analy* or model*)).tw. (33792) |
| 29 | (markov or markow or monte carlo).tw. (99281) |
| 30 | quality-adjusted life years/ (26577) |
| 31 | (QOLY or QOLYs or HRQOL or HRQOLs or QALY or QALYs or QALE or QALEs).tw. (50975) |
| 32 | ((adjusted adj (quality or life)) or (willing* adj2 pay) or sensitivity analys*s).tw. (98325) |
| 33 | or/18–32 (2279891) |
| 34 | 17 and 33 (242) |
| 35 | 34 use pmoz,cctr,coch,dare,clhta (57) |
| 36 | 17 use cleed (1) |
| 37 | or/35–36 (58) |
| 38 | limit 37 to english language [Limit not valid in CDSR,DARE; records were retained] (56) |
| 39 | limit 38 to yr=“2010 -Current” [Limit not valid in DARE; records were retained] (37) |
| 40 | exp prostate tumor/ (181348) |
| 41 | prostate/ (74575) |
| 42 | exp neoplasm/ (6495582) |
| 43 | and/41–42 (38033) |
| 44 | (prostat* adj3 (cancer* or carcinoma* or neoplas* or tumo?r* or adenoma* or adenocarcinoma* or malignan* or metasta*)).tw. (277087) |
| 45 | prostatectomy/ (69779) |
| 46 | prostatectom*.tw. (63158) |
| 47 | or/40,43–46 (359573) |
| 48 | genetic screening/ (88435) |
| 49 | ((genetic* or gene or genes or genome or genomes or genomic* or 17-gene) adj2 (test or tests or testing or panel* or assess* or screen* or profil* or algorithm* or combinatorial or prognosis or prognostic*)).tw. (235791) |
| 50 | gene expression profiling/ (171701) |
| 51 | ((gene expression adj (profiling* or monitoring* or analys?s or test or tests or testing)) or transcript expression analys?s or (transcriptome adj (analys?s or profiling*)) or (mrna adj differential display*)).tw. (69757) |
| 52 | ((cell cycle progression adj (score or scores or test or tests or testing or assay* or signature* or instrument*)) or (CCP adj (score or scores or test or tests or testing)) or cell cycle gene expression assay* or cell cycle proliferation gene* or RNA profiling test* or molecular assay* or prostate cancer assay* or genomic prostate score* or molecular diagnostic assay* or multigene expression assay*).tw. (5822) |
| 53 | or/48–52 (445179) |
| 54 | 47 and 53 (6881) |
| 55 | prolaris*.tw. (31) |
| 56 | or/54–55 (6889) |
| 57 | Economics/ (251267) |
| 58 | Health Economics/ or exp Pharmacoeconomics/ (214674) |
| 59 | Economic Aspect/ or exp Economic Evaluation/ (394850) |
| 60 | (econom* or price or prices or pricing or priced or discount* or expenditure* or budget* or pharmacoeconomic* or pharmaco-economic*).tw. (686871) |
| 61 | exp “Cost”/ (510897) |
| 62 | cost*.ti. (234727) |
| 63 | cost effective*.tw. (250095) |
| 64 | (cost* adj2 (util* or efficacy* or benefit* or minimi* or analy* or saving* or estimate* or allocation or control or sharing or instrument* or technolog*)).ab. (156523) |
| 65 | Monte Carlo Method/ (50881) |
| 66 | (decision adj1 (tree* or analy* or model*)).tw. (33792) |
| 67 | (markov or markow or monte carlo).tw. (99281) |
| 68 | Quality-Adjusted Life Years/ (26577) |
| 69 | (QOLY or QOLYs or HRQOL or HRQOLs or QALY or QALYs or QALE or QALEs).tw. (50975) |
| 70 | ((adjusted adj (quality or life)) or (willing* adj2 pay) or sensitivity analys*s).tw. (98325) |
| 71 | or/57–70 (1871276) |
| 72 | 56 and 71 (183) |
| 73 | limit 72 to english language [Limit not valid in CDSR,DARE; records were retained] (175) |
| 74 | limit 73 to yr=“2010 -Current” [Limit not valid in DARE; records were retained] (124) |
| 75 | 74 use emez (89) |
| 76 | 39 or 75 (126) |
| 77 | 76 use pmoz (26) |
| 78 | 76 use emez (89) |
| 79 | 76 use coch (8) |
| 80 | 76 use cctr (1) |
| 81 | 76 use clhta (1) |
| 82 | 76 use cleed (1) |
| 83 | 76 use dare (0) |
| 84 | remove duplicates from 76 (104) |